Amgen Inc
Current role
AMGN
James Bradner
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Bradner
The proxy statement of Amgen Inc reports total compensation of $14,914,381 for James Bradner in fiscal 2024, including a base salary of $1,214,331.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Amgen Inc (AMGN)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Amgen Inc
Other people whose current roles at this company are on record from its filings.
- Robert Bradway CEO
- David W. Meline CFO
- Thomas Dittrich CFO
- David M. Reese, M.D. CTO
- Sean Bruich CTO
- Jonathan P. Graham General Counsel
- Linda H. Louie Chief Accounting Officer
- Matthew C. Busch Chief Accounting Officer
- Amy E. Miles Board Member
- Michael V. Drake Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Amgen Inc (AMGN) | Executive Vice President, Research and Development | $1,214,331 | $14,914,381 |
Recent activity
No call appearances or filed executive changes recorded yet.